FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety

FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety

Abstract Background Multidrug-resistant Gram-negative bacterial (MRGNB) infections represent a major public health threat. Cancer patients and, among them, hematological patients are most vulnerable to these infections. Gut colonization by MRGNB is a common phenomenon occurring during hospitalizatio...

Full description

Bibliographic Details
Main Authors: Ainhoa Fernández Moreno, Lucía Lavín-Alconero, Paula López de Ugarriza, Laura Solán Blanco, Sara Cáceres Hernández, Juan Miguel Bergua Burgués, María Izquierdo de Miguel, Ana Julia González Huerta, Marta Polo Zarzuela, Blanca Boluda, Karem Humala, Maria Luisa Calabuig, Maria Luz Amigo, Marián Cuesta Casas, María del Mar García-Saiz, Ana Fernández Verdugo, Javier Fernández Domínguez, Teresa Bernal
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Trials
Subjects:
Hematological neoplasms
Febrile neutropenia
Prophylaxis
Gram-negative resistant bacteria
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13063-023-07702-5

Internet

https://doi.org/10.1186/s13063-023-07702-5

Similar Items